BCN Biosciences
BCN Biosciences is developing novel drugs in oncology as well as for the protection of normal tissues from radiation damage. They are committed to improving cancer treatment and diagnosis. The company manufactures innovative and effective medicines to treat cancer, one of the most serious diseases, with a team of experts in both drug discovery and oncology.
Industries
biotechnology
health-care
manufacturing
medical
pharmaceutical
Nr. of Employees
small (1-50)
BCN Biosciences
Pasadena, California, United States, North America
Patents
Methods of treating radiation induced gastrointestinal syndrome (RIGS) and related disease states using compound 512
US-11534437-B2
View DetailsMethods of treating radiation induced gastrointestinal syndrome (RIGS) and related disease states using YEL002/BCN057
US-11364231-B2
View Details
Methods of treating radiation induced gastrointestinal syndrome (RIGS) and related disease states using compound 512
US-11534437-B2
View DetailsMethods of treating radiation induced gastrointestinal syndrome (RIGS) and related disease states using YEL002/BCN057
US-11364231-B2
View DetailsProducts
Small Molecule Drugs in RAS Oncology
Small molecule drugs developed to target RAS-related cancer pathways for therapeutic intervention.
Small Molecule Drugs in Immune Oncology
Small molecule drugs designed to modulate immune system responses to treat cancer.
Small Molecule Drugs in RAS Oncology
Small molecule drugs developed to target RAS-related cancer pathways for therapeutic intervention.
Small Molecule Drugs in Immune Oncology
Small molecule drugs designed to modulate immune system responses to treat cancer.